Lung Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Targeted Therapy for Lung Cancer

published 5 months ago by Dr Neil Love

Featuring perspectives from Drs Joel W Neal and Paul K Paik on the following topics: Introduction (0:00) Case: A 67-year-old man, never smoker with symptomatic metastatic adenosquamous carcinoma of the lung (1:33) Targeting ROS1 rearrangements in non-small cell lung cancer (NSCLC) (9:07) EGFR exon 19 deletion and exon 21 (L858R) point mutation in NSCLC (11:17) Recent data with agents targeting EGFR exon 20 insertions in NSCLC (28:22) Efficacy and safety of agents targeting HER2 amplification/mutation (31:56) ALK rearrangements as a therapeutic target in NSCLC (38:07) Targeting NTRK fusions in NSCLC (41:46) Available data with RET inhibitors in NSCLC (43:50) MET Exon 14 skipping mutations in NSCLC (46:36) Emerging data with agents targeting KRAS G12C mutation in NSCLC (51:47) CME information and select publications

more episodes from Research To Practice | Oncology Videos